NCT00390052View on ClinicalTrials.gov

3-AP in Treating Patients With Advanced or Metastatic Solid Tumors

PHASE1CompletedINTERVENTIONAL
Enrollment

24

Participants

Timeline

Start Date

December 31, 2006

Primary Completion Date

February 28, 2011

Conditions
Unspecified Adult Solid Tumor, Protocol Specific
Interventions
DRUG

triapine

Given IV and orally

OTHER

pharmacological study

correlative study

PROCEDURE

laboratory biomarker analysis

Correlative study

Trial Locations (1)

91010

City of Hope, Duarte

All Listed Sponsors
lead

National Cancer Institute (NCI)

NIH

NCT00390052 - 3-AP in Treating Patients With Advanced or Metastatic Solid Tumors | Biotech Hunter | Biotech Hunter